Revance Therapeutics | RVNC - Ebit



Ebit Veränderung Datum
AbbVie USD 5.81B 4.36B 2025-12
ALKERMES USD -10.95M 100.03M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Cara Therapeutics USD -5.94M 3.55M 2025-09
Coherus Biosciences USD -39.08M 3.65M 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
J&J USD 5.11B 2.3B 2025-12
Merck USD 6.24B 1.32B 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
P&G USD 5.66B 194M 2025-12
Pacira USD 3.19M 9.96M 2025-12
Supernus Pharmaceuticals USD 13.82M 74.01M 2025-12